Evidence map›Paper›PMID 37945664›Full record

ArticleScientific reports2023

Performance of standardized cancer patient pathways in Sweden visualized using observational data and a state-transition model.

Sixten Borg, Ann-Sofi Hörstedt, Tobias Carlsson, Mef Nilbert, Anna-Maria Larsson, Björn Ohlsson

Abstract read
In one paragraph

Article in Scientific reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Observational
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Sixten BorgRegional Cancer Centre South, RCC Syd, Scheelevägen 8, 223 81, Lund, Sweden. sixten.borg@skane.se.
Ann-Sofi HörstedtRegional Cancer Centre South, RCC Syd, Scheelevägen 8, 223 81, Lund, Sweden.
Tobias CarlssonRegional Cancer Centre South, RCC Syd, Scheelevägen 8, 223 81, Lund, Sweden.
Mef NilbertRegional Cancer Centre South, RCC Syd, Scheelevägen 8, 223 81, Lund, Sweden.
Anna-Maria Larsson *Regional Cancer Centre South, RCC Syd, Scheelevägen 8, 223 81, Lund, Sweden.
Björn Ohlsson *Regional Cancer Centre South, RCC Syd, Scheelevägen 8, 223 81, Lund, Sweden.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Standardized Cancer Patient Pathways (CPPs) were introduced in Swedish healthcare starting in 2015 to improve diagnostics for patients with symptoms of cancer, patient satisfaction and equity of care between healthcare providers. An inclusion target and a time target were set. Our primary aim was to visualize the patient population going through CPPs, in terms of investigation time and indications of the various outcomes including cancer diagnoses. Our secondary aims were to examine if targets were met, and to examine frequencies of undetected cancer. We collected data from 19,204 patients starting in a CPP, and 7895 patients diagnosed with cancer in 2018 in a region of Sweden. A state transition model was developed and used as analytical framework, and patients were mapped over time in the states of the model. Visualization of the patient-flow through the model illustrates speed of investigation, time to treatment, frequencies of detected and undetected cancer. Twelve CPPs out of 28 met the inclusion target, five met the time target. After suspicion of cancer rejected, 0.8% of patients were diagnosed with the primarily suspected cancer, 1.0% with another cancer. In patients not meeting the criteria for well-founded suspicion less than 3% were later diagnosed with cancer. The visualization of the patient flow into and through standardized cancer patient pathways illustrates investigation time, events occurring and outcomes. The use of standardized cancer patient pathways detects cancer efficiently.

Indexed as

NeoplasmsHealth PersonnelHumansPatient SatisfactionSweden

Identifiers

PMID37945664
PMCPMC10636179

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.